ONCORUS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ONCORUS and buy or sell other stocks, ETFs, and their options commission-free!

About ONCR

Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. It develops an immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. 

CEO
Craig R. Jalbert
CEOCraig R. Jalbert
Employees
Employees
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
2015
Founded2015
Employees
Employees

ONCR Key Statistics

Market cap
3.29M
Market cap3.29M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
404.10K
Average volume404.10K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.47
52 Week high$0.47
52 Week low
$0.01
52 Week low$0.01

Stock Snapshot

ONCORUS(ONCR) stock is priced at $0.13, giving the company a market capitalization of 3.29M. It carries a P/E multiple of -0.04.

During the trading day, ONCORUS(ONCR) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 404.1K.

The stock's 52-week range extends from a low of $0.01 to a high of $0.47.

The stock's 52-week range extends from a low of $0.01 to a high of $0.47.

People also own

Based on the portfolios of people who own ONCR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.